2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9804):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W004356S
    (Rac)-Tenofovir alafenamide-d5
    		98.13%
    (2R)-Isopropyl 2-((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate-d5 is the deuterium labeled (2R)-isopropyl 2-((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate[
    (Rac)-Tenofovir alafenamide-d<sub>5</sub>
  • HY-10274S
    Dabigatran etexilate-d13
    		99.28%
    Dabigatran etexilate-d13 is the deuterium labeled Dabigatran etexilate. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran. Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation.
    Dabigatran etexilate-d<sub>13</sub>
  • HY-W014225S
    3-Phenoxybenzoic acid-13C6
    		99.29%
    3-Phenoxybenzoic acid-13C6 is the 13C6 labeled 3-Phenoxybenzoic acid. 3-Phenoxybenzoic acid is the metabolite of pyrethroid insecticides. 3-Phenoxybenzoic acid induces immunotoxicity and oxidative stress, and inhibits the phagocytic ability of macrophages.
    3-Phenoxybenzoic acid-<sup>13</sup>C<sub>6</sub>
  • HY-14397S
    Indomethacin-d4
    		99.78%
    Indomethacin-d4 is a deuterium labeled Indomethacin. Indomethacin is a potent, blood-brain permeable and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for human COX-1 and COX-2, respectively, in CHO cells. Indomethacin disrupts autophagic flux by disturbing the normal functioning of lysosomes.
    Indomethacin-d<sub>4</sub>
  • HY-163164S
    18:1-17:1-18:1 TG-d5
    		99.00%
    18:1-17:1-18:1 TG-d5, 1,3-dioleoyl-2-heptadec-10Z-enoyl-glycerol-d5, is a deuterated substance.
    18:1-17:1-18:1 TG-d<sub>5</sub>
  • HY-15656S
    Ceritinib-d7
    		98.00%
    Ceritinib-d7 is a deuterium labeled Ceritinib. Ceritinib is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor.
    Ceritinib-d<sub>7</sub>
  • HY-B0151S
    Pregnenolone-d4
    Pregnenolone-d4 is the deuterium labeled Pregnenolone. Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone can protect the brain from cannabis intoxication. Pregnenolone is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels.
    Pregnenolone-d<sub>4</sub>
  • HY-78139S1
    L-Xylose-2-13C
    		≥99.0%
    L-Xylose-2-13C ((L-(-)-Xylose-2-13C)) is the 13C labeled L-Xylose (HY-78139). L-Xylose (L-(-)-Xylose) is a rare sugar and the levorotatory form of Xylose (HY-N0537). L-Xylose can be used as a raw material for the synthesis of various drugs and bioactive molecules.
    L-Xylose-2-<sup>13</sup>C
  • HY-B0390S
    Mestranol-d2
    		≥99.0%
    Mestranol-d2 is the deuterium labeled Mestranol. Mestranol is an inactive proagent and becomes biologically active on conversion to ethinyl estradiol (EE). Mestranol acts as an estrogen receptor agonist. Mestranol combines with a progestin in vivo and can be used for the research of menopausal hormone or menstrual disorders. Mestranol-d2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    Mestranol-d<sub>2</sub>
  • HY-127035S2
    Tristearin-d40
    		99.12%
    Tristearin-d40 is the deuterium labeled Tristearin.
    Tristearin-d<sub>40</sub>
  • HY-W127457S
    1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22
    		≥99.0%
    1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d22 is deuterium labeled 1,2-Dihexanoyl-sn-glycero-3-phosphocholine.
    1,2-Dihexanoyl-sn-glycero-3-phosphocholine-d<sub>22</sub>
  • HY-176258S
    Growth Hormone 22, Arg-13C6,15N4, Lys-13C6,15N2
    Growth Hormone 22, Arg-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>4</sub>, Lys-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>2</sub>
  • HY-W141857
    L-Alanine-2-d1
    L-Alanine-2-d1 is the deuterium labeled L-Alanine-2[1].
    L-Alanine-2-d1
  • HY-A0003S
    Lenalidomide-d5
    		99.32%
    Lenalidomide-d5 is deuterium labeled Lenalidomide. Lenalidomide (CC-5013), a derivative of Thalidomide, acts as molecular glue. Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide (CC-5013) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells.
    Lenalidomide-d<sub>5</sub>
  • HY-B1556S
    Benzyl salicylate-d4
    		≥99.0%
    Benzyl salicylate-d4 is the deuterium labeled Benzyl salicylate.
    Benzyl salicylate-d<sub>4</sub>
  • HY-132953S
    Formaldehyde 2,4-dinitrophenylhydrazone-d3
    		≥99.0%
    Formaldehyde 2,4-dinitrophenylhydrazone-d3 is the deuterium labeled Formaldehyde 2,4-dinitrophenylhydrazone.
    Formaldehyde 2,4-dinitrophenylhydrazone-d<sub>3</sub>
  • HY-D0844S
    Glutathione oxidized-13C4,15N2
    		99.80%
    Glutathione oxidized-13C4,15N2 is the 13C and 15N labeled Glutathione oxidized (HY-D0844). Glutathione oxidized is produced by the oxidation of glutathione. Detoxification of reactive oxygen species is accompanied by production of glutathione oxidized. Glutathione oxidized can be used for the research of sickle cells and erythrocytes.
    Glutathione oxidized-<sup>13</sup>C<sub>4</sub>,<sup>15</sup>N<sub>2</sub>
  • HY-139392S
    Octanoyl-L-carnitine-d3 chloride
    		99.97%
    Octanoyl-L-carnitine-d3 (chloride) is the deuterium labeled Octanoyl-L-carnitine chloride.
    Octanoyl-L-carnitine-d<sub>3</sub> chloride
  • HY-B0716S1
    Urapidil-d3
    		99.93%
    Urapidil-d3 is the deuterium labeled Urapidil. Urapidil is an α1 adrenoreceptor antagonist and a 5-HT1A receptor agonist.
    Urapidil-d<sub>3</sub>
  • HY-134670S1
    α-Hydroxymetoprolol-d7
    		99.09%
    α-Hydroxymetoprolol-d7 is the deuterium labeled α-Hydroxymetoprolol.
    α-Hydroxymetoprolol-d<sub>7</sub>